V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 300006594 | 300004698 | 1.58 | 73.5 | Palliative (P) | null | 2018-07-17 | Cetuximab+Cisplatin+FU (> Cycle 2) | Y | N | 300017469 | CETUXIMAB |
| 300006595 | 300004698 | 1.67 | null | null | 2015-09-04 | 2015-11-10 | Trial Unspecified | null | null | 300017469 | CETUXIMAB + RT |
| 300006596 | 300004699 | 1.73 | 90 | Curative (C) | 2015-02-17 | 2015-04-01 | CETUXIMAB + RT | 02 | Y | 300017473 | CAPECITABINE + RT |
| 300006600 | 300004702 | null | 80 | Neo-adjuvant (N) | 2013-09-05 | 2013-09-06 | CAPECITABINE + OXALIPLATIN | 2 | N | 300017490 | HYDROXYCARBAMIDE |
| 300006601 | 300006946 | 1.77 | 90 | Adjuvant (A) | 2015-05-23 | 2015-05-30 | Docetaxel 75mg/m2 (21 day) | 2 | N | 300017495 | GEMCARBO |
| 300006603 | 300004705 | 1.65 | null | Curative (C) | 2014-10-10 | 2014-11-26 | Carboplatin + Docetaxel | N | null | 300017511 | CETUXIMAB + CISPLATIN + FLUOROURACIL |
| 300006604 | 300006947 | null | 52.7 | Palliative (P) | 2016-10-02 | 2016-11-03 | CETUXIMAB | N | N | 300017512 | CAPECITABINE + OXALIPLATIN |
| 300006605 | 300004708 | 1.47 | 62.2 | Palliative (P) | null | 2013-05-04 | CISPLATIN + DOCETAXEL + FLUOROURACIL | null | null | 300017514 | OXALIPLATIN + MDG |
| 300006606 | 300004709 | 1.71 | 81 | Curative (C) | 2016-03-22 | 2017-06-17 | Capecitabine | N | Y | 300017523 | NOT MATCHED |
| 300006607 | 300004710 | 1.63 | 90.5 | Curative (C) | 2018-02-06 | 2018-02-23 | Trial Unspecified | N | N | 300017525 | CAPECITABINE |
| 300006610 | 300008125 | 1.67 | 46.2 | Curative (C) | null | 2013-06-13 | Capecitabine + Oxaliplatin 14day | N | null | 300017536 | OXALIPLATIN + MDG |
| 300006611 | 300004712 | null | null | Neo-adjuvant (N) | 2017-11-28 | 2017-12-06 | CETUXIMAB | N | N | 300017545 | TRIAL |
| 300006612 | 300004712 | 1.66 | null | null | 2017-08-26 | 2018-07-02 | Trial Unspecified | N | null | 300017545 | CYCLOPHOSPHAMIDE |
| 300006613 | 300004713 | 1.59 | 88.35 | Curative (C) | 2013-04-05 | 2013-04-30 | Cetuximab 7 day (>Cycle 2) | N | Y | 300017561 | CETUXIMAB + RT |
| 300006614 | 300004714 | 1.7 | 55 | Curative (C) | 2016-06-08 | 2016-06-12 | CETUXIMAB | N | N | 300017561 | GEMCARBO |
| 300006615 | 300004715 | null | null | Adjuvant (A) | 2014-12-14 | 2015-01-05 | CETUXIMAB + CISPLATIN + FU | N | N | 300017568 | TRIAL |
| 300006616 | 300004716 | 1.55 | 83.1 | Curative (C) | 2015-12-15 | 2015-12-21 | CETUXIMAB + RT | N | Y | 300017581 | GEMCARBO |
| 300006617 | 300004718 | 1.63 | 57.8 | Curative (C) | 2013-07-24 | 2013-08-28 | Cisplatin + Docetaxel +Fluorouracil | N | N | 300017583 | CISPLATIN + FLUOROURACIL |
| 300006618 | 300006952 | null | null | Neo-adjuvant (N) | null | 2013-10-26 | Cisplatin | N | Y | 300017602 | CARBOPLATIN + RT |
| 300006619 | 300006952 | 1.7 | 55.5 | Curative (C) | 2016-10-01 | 2017-03-14 | CETUXIMAB + RT | N | Y | 300017602 | CISPLATIN |
| 300006620 | 300004719 | 1.85 | 54 | null | 2016-04-17 | 2016-05-01 | CARBOPLATIN + RT | 2 | Y | 300017622 | CARBOPLATIN |
| 300006621 | 300004719 | 1.74 | 73.8 | Neo-adjuvant (N) | 2015-06-19 | 2015-07-29 | LUX TRIAL | 02 | N | 300017622 | CETUXIMAB + RT |
| 300006622 | 300004719 | null | null | Curative (C) | 2015-11-08 | 2015-11-09 | CARBOPLATIN | N | N | 300017622 | GEMCARBO |
| 300006623 | 300004720 | 1.67 | 74 | Curative (C) | 2017-06-06 | 2017-07-25 | Cetuximab + Radiotherapy Maint | N | Y | 300017639 | CETUXIMAB |
| 300006624 | 300004720 | 1.62 | 52.3 | Disease modification (D) | 2017-03-03 | 2017-04-15 | CARBOPLATIN + ETOPOSIDE | N | N | 300017639 | CARBOPLATIN |
| 300006625 | 300004721 | 1.68 | null | Neo-adjuvant (N) | 2014-11-15 | 2015-11-21 | Trial Unspecified | 02 | N | 300017649 | NIVOLUMAB |
| 300006626 | 300004722 | 1.67 | 78.7 | Curative (C) | 2015-02-18 | 2015-02-21 | CARBOPLATIN + PACLITAXEL | null | null | 300017655 | ESPAC TRIAL |
| 300006627 | 300004724 | null | 57.7 | Curative (C) | 2015-07-12 | 2015-07-20 | CAP + RT | N | Y | 300017655 | CETUXIMAB + RT |
| 300006628 | 300004725 | 1.65 | null | Curative (C) | 2016-08-29 | 2016-09-05 | Cetuximab + Radiotherapy Maint | null | Y | 300017661 | CARBOPLATIN |
| 300006629 | 300004727 | 1.65 | 20.2 | Disease modification (D) | 2014-04-25 | 2014-05-09 | Capecitabine | N | N | 300017661 | CAPECITABINE + OXALIPLATIN |
| 300006630 | 300004727 | 1.7 | 72.4 | Disease modification (D) | 2017-11-07 | 2017-12-09 | Capecitabine + Oxaliplatin 21day | Y | N | 300017661 | TRIAL |
| 300006631 | 300004727 | 1.62 | null | Curative (C) | 2014-06-19 | 2014-06-21 | Oxaliplatin + Modified de Gramont | N | N | 300017661 | CAPECITABINE + OXALIPLATIN |
| 300006632 | 300004730 | 1.81 | null | Adjuvant (A) | null | 2015-08-23 | DE-ESCALATE TRIAL | Y | null | 300017699 | CETUXIMAB + RT |
| 300006633 | 300004731 | 1.82 | 86.1 | Curative (C) | 2016-09-06 | 2016-09-17 | NIVOLUMAB | Y | N | 300017707 | CAPECITABINE + OXALIPLATIN |
| 300006634 | 300004731 | null | 79 | Adjuvant (A) | null | 2013-12-10 | Paclitaxel 7 day | N | N | 300017707 | IRINOTECAN + MDG |
| 300006635 | 300004733 | 1.64 | 50.3 | null | 2017-03-07 | 2017-03-23 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | 300017710 | CISPLATIN + FLUOROURACIL |
| 300006636 | 300004734 | 1.75 | 71.7 | Curative (C) | 2013-05-06 | 2013-05-12 | Carboplatin AUC 6 - 10 | N | Y | 300017721 | CARBOPLATIN |
| 300006637 | 300004735 | 1.76 | 52 | Palliative (P) | 2016-09-21 | 2016-09-22 | Trial Unspecified | N | N | 300017727 | TRIAL |
| 300006638 | 300006959 | 1.64 | 88 | Palliative (P) | 2017-02-13 | 2017-02-28 | CISPLATIN + FLUOROURACIL | N | N | 300017743 | CISPLATIN |
| 300006639 | 300004738 | 1.81 | 92.6 | null | 2016-08-16 | 2016-08-17 | KESTREL Trial | N | null | 300017751 | DE-ESCALATE TRIAL |
| 300006640 | 300006961 | 1.73 | 57 | Curative (C) | 2015-12-29 | 2015-12-29 | Docetaxel | 2 | N | 300017752 | CISPLATIN + FLUOROURACIL |
| 300006641 | 300006962 | null | 98.8 | Curative (C) | 2015-10-21 | 2015-11-01 | CARBOPLATIN + RT | 2 | Y | 300017758 | CETUXIMAB + RT |
| 300006642 | 300004742 | 1.55 | 74.7 | Neo-adjuvant (N) | 2016-11-22 | 2016-11-28 | CETUXIMAB | N | N | 300017758 | OXALIPLATIN + MDG |
| 300006643 | 300004743 | 1.84 | 66 | Palliative (P) | 2016-06-28 | 2016-08-13 | Carboplatin AUC 6 - 10 | 02 | null | 300017768 | CARBOPLATIN + PACLITAXEL |
| 300006644 | 300004744 | 1.58 | 56.7 | null | 2014-05-17 | 2014-05-17 | PEMBROLIZUMAB | Y | null | 300017771 | FLUOROURACIL |
| 300006645 | 300004745 | null | 77 | Curative (C) | null | 2014-07-26 | PACLITAXEL | null | null | 300017779 | CAPECITABINE + GEMCITABINE |
| 300006646 | 300004745 | 1.67 | 47 | Neo-adjuvant (N) | 2013-02-17 | 2013-04-14 | CAV | 02 | null | 300017779 | OXALIPLATIN + MDG |
| 300006647 | 300006965 | 1.67 | null | Curative (C) | 2015-12-08 | 2015-12-08 | Trial Unspecified | 02 | N | 300017803 | CARBOPLATIN + CETUXIMAB + FU |
| 300006648 | 300004747 | 1.73 | 58.4 | Curative (C) | 2016-10-01 | 2016-10-07 | Capecitabine | N | null | 300017808 | CHOP R |
| 300006649 | 300004748 | 1.6 | 74.6 | Curative (C) | 2016-05-06 | 2016-05-11 | CAPECITABINE + CETUXIMAB + CISPLATIN | 02 | N | 300017811 | IRINOTECAN + MDG |